What's new

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine,tenofovir disoproxil, Date of authorisation: 28/04/2017, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin,...

Next Article

Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Da...

Related Posts

Human medicines European public assessment report (EPAR): Memantine Mylan, memantine, Date of authorisation: 21/04/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

EMEA-003520-PIP01-23

EMEA-003520-PIP01-23

Mar 21, 2025  0

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 7, 2025  0